FDA Adds Warning on Risk for PE, Death With Higher-Dose Xeljanz - Medscape

FDA Adds Warning on Risk for PE, Death With Higher-Dose Xeljanz  Medscape

The FDA has approved new warnings on risk for blood clots and death with the 10-mg twice-daily dose of tofacitinib, based on data from an ongoing ...